AHK-Cu

AHK-Cu, a copper peptide distinct from GHK-Cu, has been studied for its effects on hair follicles in laboratory (in-vitro) conditions. However, this research was conducted on isolated follicles in a dish and has not been validated in human scalp trials, limiting the clinical applicability of these findings.

The hair growth research that does exist in the copper peptide space was conducted on AHK-Cu, a different copper peptide, not GHK-Cu. Furthermore, this research was performed on isolated hair follicles in a laboratory dish rather than on human scalps in vivo, significantly limiting its applicability to real-world hair restoration claims made for GHK-Cu.

The hair growth studies involving AHK-Cu were performed on follicles in a laboratory dish (in vitro), not on living human scalps. This significantly limits the applicability of those findings to real-world hair regrowth outcomes. The speaker uses this to illustrate how mechanistic plausibility and in-vitro data can be misrepresented as clinical efficacy.

AHK-Cu, a copper peptide distinct from GHK-Cu, has been studied in the context of hair follicle biology. However, the available research was conducted on isolated follicles in a dish rather than in human scalp trials, limiting the clinical applicability of any findings.

The speaker identifies a critical misattribution in the GHK-Cu hair growth narrative: the existing hair growth research was conducted on a different copper peptide, AHK-Cu (Alanine-Histidine-Lysine-Copper), not GHK-Cu. This distinction is important for consumers evaluating GHK-Cu specifically for hair regrowth purposes. The two peptides are related but distinct compounds and should not be conflated.

The hair growth research that exists and is often associated with GHK-Cu was actually performed on a different copper peptide, AHK-Cu, not GHK-Cu. Furthermore, this research was conducted on follicles in a laboratory dish (in vitro), not on human scalps, making extrapolation to real-world hair regrowth outcomes premature.